Arlington Financial Advisors LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,491 shares of the medical equipment provider’s stock after selling 403 shares during the quarter. Intuitive Surgical comprises 1.4% of Arlington Financial Advisors LLC’s holdings, making the stock its 23rd largest position. Arlington Financial Advisors LLC’s holdings in Intuitive Surgical were worth $7,042,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. Bennett Selby Investments LP boosted its stake in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC lifted its stake in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. boosted its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares during the last quarter. FSM Wealth Advisors LLC grew its stake in Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC lifted its stake in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on ISRG. Barclays upped their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Evercore ISI boosted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $613.10.
Intuitive Surgical Stock Performance
ISRG opened at $582.98 on Friday. The business’s 50-day simple moving average is $554.03 and its 200-day simple moving average is $513.12. The company has a market cap of $207.65 billion, a P/E ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.
Insiders Place Their Bets
In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,940 shares of company stock valued at $3,333,485. 0.90% of the stock is owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- 5 discounted opportunities for dividend growth investors
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 02/03 – 02/07
- What is the FTSE 100 index?
- Meta Platforms Continues to Prove Why It’s a Premier Play on AI
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.